CD57 抗体
Our Local Distributor
北京 101111
Quick Overview for CD57 抗体 (ABIN7865564)
抗原
See all CD57 (B3GAT1) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
原理
- anti-CD57 mouse monoclonal, NK-1, purified
-
纯化方法
- affinity chromatography
-
免疫原
- human PBL
-
亚型
- IgM kappa
-
-
-
-
应用备注
-
ICC/IF_dilution: 1:100-1:200 (0.5-1.0 μg/mL)
FACS_dilution: 0.5-1.0 μg/million cells in 0.1 ml
IHC-paraffin_dilution: 1:50-1:100 (1-2 μg/mL, microwave treatment in 10 mM Tris with 1 mM EDTA pH 9.0 recommended)
IHC-frozen_dilution: 1:50-1:100 (1-2 μg/mL)
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 100 μg/mL
-
缓冲液
- PBS with 0.02 % sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
储存方法
- store at 2 - 8 °C
-
-
- CD57 (B3GAT1) (beta-1,3-Glucuronyltransferase 1 (Glucuronosyltransferase P) (B3GAT1))
-
别名
- CD57
-
背景
- NK-1 reacts with CD57, a 110 kDa antigen present on the surface of human NK-cells and T-cell subsets. In adult peripheral blood 20 % of mononuclear cells are positive. Other positive tissues include peripheral nerves (myelin-associated glycoprotein) and prostate. Anti-CD57 also stains neuroendocrine cells and their derived tumors, including carcinoid tumor and medulloblastomas. Anti-CD57 can also be useful in separating type B3 thymoma from thymic carcinoma when combined with a panel that includes antibodies against GLUT1, CD5, and CEA. Positive control: Lymph node or tonsil.
-
途径
- Glycosaminoglycan Metabolic Process
抗原
-